Diabetes & Vascular Disease Research

Scope & Guideline

Exploring the vital connections between diabetes and cardiovascular disease.

Introduction

Welcome to the Diabetes & Vascular Disease Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Diabetes & Vascular Disease Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1479-1641
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationDIABETES VASC DIS RE / Diabetes Vasc. Dis. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Diabetes & Vascular Disease Research' focuses on the intersection of diabetes and vascular health, emphasizing research that explores the relationships between diabetes, cardiovascular diseases, and related complications. Its scope encompasses clinical studies, epidemiological research, and molecular investigations aimed at understanding the mechanisms underlying these conditions and improving patient outcomes.
  1. Diabetes and Cardiovascular Disease Interactions:
    Researching the impact of diabetes on cardiovascular health, including the prevalence of heart disease among diabetic patients and mechanisms of cardiovascular complications.
  2. Microvascular and Macrovascular Complications:
    Exploring the pathophysiology, risk factors, and treatment approaches for complications associated with diabetes, such as diabetic nephropathy, retinopathy, and peripheral artery disease.
  3. Innovative Therapeutic Approaches:
    Investigating new medications, treatment regimens, and interventions aimed at managing diabetes and its vascular complications, including pharmacological studies and real-world applications.
  4. Epidemiological Studies:
    Conducting population-based studies to assess the incidence, prevalence, and risk factors associated with diabetes and its complications across different demographics.
  5. Biomarkers and Molecular Mechanisms:
    Identifying biomarkers and understanding the molecular pathways involved in diabetes and vascular dysfunction to facilitate early diagnosis and targeted therapy.
Recent publications in 'Diabetes & Vascular Disease Research' reveal significant trends and emerging themes that are reshaping the understanding of diabetes and its vascular implications. These themes reflect advancements in technology, evolving treatment paradigms, and a deeper understanding of disease mechanisms.
  1. Role of Novel Therapeutics:
    An increasing focus on the efficacy of novel diabetes medications, particularly sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, in reducing cardiovascular and renal risks associated with diabetes.
  2. Microvascular Complications and Inflammation:
    Emerging research is highlighting the role of inflammation in the development of microvascular complications, such as diabetic retinopathy and nephropathy, leading to new therapeutic targets.
  3. Integration of Technology in Diabetes Management:
    The use of continuous glucose monitoring systems and digital health technologies is trending, with research exploring their impact on glycemic control and patient outcomes.
  4. Psychosocial Factors in Diabetes Management:
    There is a growing recognition of the importance of psychological and social factors in diabetes management, with studies investigating how these factors influence disease progression and treatment adherence.
  5. Longitudinal and Cohort Studies:
    A trend towards conducting longitudinal studies that track diabetes progression and its vascular complications over time, providing insights into long-term outcomes and risk factors.

Declining or Waning

While certain areas of research maintain a robust presence in the journal, others appear to be declining in frequency or relevance. This decline may suggest shifts in research priorities or advancements in understanding that make some previously emphasized topics less prominent.
  1. Historical Cardiovascular Risk Factors:
    Research focusing on traditional cardiovascular risk factors in isolation, such as cholesterol levels or hypertension, appears to be waning as studies increasingly emphasize the interconnectivity between diabetes and broader health outcomes.
  2. Basic Science Approaches without Clinical Applications:
    There seems to be a decrease in purely basic science studies that do not directly translate to clinical practice or patient outcomes, as the journal shifts towards more translational research that impacts patient care.
  3. Single-Factor Studies:
    Studies that examine the effects of diabetes on vascular health in isolation without considering the multifactorial nature of these diseases are becoming less common, reflecting a trend towards a more holistic approach in research.

Similar Journals

Acta Angiologica

Exploring the Frontiers of Cardiovascular Science
Publisher: VIA MEDICAISSN: 1234-950XFrequency: 4 issues/year

Acta Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.

Vascular

Shaping the future of vascular research and treatment.
Publisher: SAGE PUBLICATIONS LTDISSN: 1708-5381Frequency: 6 issues/year

Vascular is a premier academic journal published by SAGE Publications Ltd, focusing on a wide range of disciplines within the fields of cardiology, cardiovascular medicine, surgery, and radiology. Established in 1993 and continuing through 2024, this journal serves as an essential resource for researchers and professionals seeking to advance their understanding of vascular health and disease. With an impressive categorization in the Q3 quartile for cardiology and cardiovascular medicine, and Q2 quartile for surgery, Vascular has established itself as a reputable platform for disseminating cutting-edge research and innovative clinical practices. The journal's positioning in various Scopus Ranks reflects its relevance and contribution to advancing these critical medical fields, making it an indispensable tool for students, clinicians, and researchers alike. For those interested in keeping abreast of the latest developments, Vascular offers a rich repository of articles that contribute significantly to the global discourse on vascular diseases.

VASCULAR MEDICINE

Transforming research into practice for superior vascular care.
Publisher: SAGE PUBLICATIONS LTDISSN: 1358-863XFrequency: 6 issues/year

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.

Journal of Diabetes Investigation

Empowering discoveries in endocrinology and metabolism.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

ANGIOLOGY

Bridging Research and Clinical Practice in Cardiology
Publisher: SAGE PUBLICATIONS INCISSN: 0003-3197Frequency: 10 issues/year

ANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.

MICROVASCULAR RESEARCH

Connecting Microvascular Insights to Clinical Impact
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0026-2862Frequency: 6 issues/year

Microvascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.

CLINICAL SCIENCE

Connecting Science and Practice for Enhanced Healthcare
Publisher: PORTLAND PRESS LTDISSN: 0143-5221Frequency: 24 issues/year

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

ACTA DIABETOLOGICA

Advancing Knowledge in Diabetes and Metabolism
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

DIABETES CARE

Pioneering insights for effective diabetes management.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

Cardiovascular Diabetology

Exploring the Nexus of Heart Health and Diabetes Care
Publisher: BMCISSN: Frequency: 1 issue/year

Cardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.